Genzyme Corporation / Genzyme Biosurgery recalls Mozobil (plerixafor injection) 24 mg/1.2 mL (20 mg/mL) per vial, Rx Only, For Subcutaneous Injection only, Manufactured
Recalled September 28, 2016 · FDA recall D-1518-2016 · Genzyme Corporation / Genzyme Biosurgery
Hazard
Labeling: Incorrect or Missing Lot and/or Exp. Date · FDA Class III
Units
9,530 vials
Sold at
nationwide
Description
Labeling: Incorrect or Missing Lot and/or Exp. Date
Product
Mozobil (plerixafor injection) 24 mg/1.2 mL (20 mg/mL) per vial, Rx Only, For Subcutaneous Injection only, Manufactured by: Genzyme Corporation, 500 Kendall Street, Cambridge, MA 02142 A Sanofi Company Country of Origin : United Kingdom, NDC 0024-5862-01
Manufacturer(s)
Genzyme Corporation / Genzyme Biosurgery
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →